COVID & CompanyDecember 06, 2022 | COVID & Other Viral/Infectious Disease Info All Specialties Medical Masks vs. N95 Respirators for Preventing COVID-19 Among Health Care Workers In this trial involving 29 healthcare facilities in 4 countries from May 2020 through April 2022, PCR-confirmed COVID infection occurred in approximately 10.5% of the mask group versus approximately 9.3% of the N95 group. Read full article All Specialties Outpatient Treatment of Confirmed COVID-19 Some of the key findings of this meta-analysis of antiviral therapy in the outpatient setting include: (treatment vs no-treatment) Probable reduction of hospitalization with Nirmatrelvir–ritonavir and casirivimab–imdevimab (1% vs 6%) Probable reduction in all-cause mortality with Nirmatrelvir–ritonavir (0% vs 1%) Probable improved recovery with regdanvimab (87% vs 72%) Four-day reduction in time to recovery with casirivimab-imdevimab Possible reduction in recovery rates with hydroxychloroquine Read full article